Securities in Issue

Cookie Notification

We use cookies to collect information about how our website is used and to improve the visitor experience. You can change your browser's cookie settings at any time. Please review our privacy policy for more information. OK

Number of Securities in Issue

As of 30 September 2017, the total number of ordinary shares of 0.1p each in the capital of the company in issue was 304,438,252 with each share carrying the right to one vote.


Directors and their Interests

The Directors together with their beneficial interests in the shares of the Company, as at 30 September 2016, were as follows:


Executive

Number of Shares held

%

Dr Geoffrey W Guy - Chairman

13,797,852

4.6

Mr Justin Gover - Chief Executive Officer

2,513,759

0.8

Mr Adam George - Chief Finance Officer

27, 617

<0.1

Mr. Christopher Tovey - Chief Operating Officer

2,500

<0.1

Dr Stephen Wright - Chief Medical Officer

5,915

<0.1

     

Non-executive

   

Mr James Noble

27,500

<0.1

Mr Cabot Brown

7,200

<0.1

Mr Tom Lynch

2,074

<0.1


Substantial Shareholdings

The Company has been notified, in accordance with sections 198 to 208 of the Companies Act 1985, of the following interests in the ordinary share capital of the Company:


 

Number of Shares held

%

Capital Research and Management Company

45,340,848

15.0

FMR LLC

21,058,296

7.0

Prudential plc group of companies

24,602,551

8.1

Dr Geoffrey W Guy

13,797,852

4.6


The percentage of the Company's issued share capital that is not in public hands, as per the definition in the AIM Rules, is 28.1%.

There are no restrictions on the transfer of securities.

This section of the website was last updated on: 21 December 2016.

Ways to keep up to date with GW